Lidds AB (LIDDS) - Net Assets

Latest as of September 2025: Skr1.49 Million SEK ≈ $160.56K USD

Based on the latest financial reports, Lidds AB (LIDDS) has net assets worth Skr1.49 Million SEK (≈ $160.56K USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr1.98 Million ≈ $213.40K USD) and total liabilities (Skr491.00K ≈ $52.84K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Lidds AB (LIDDS) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr1.49 Million
% of Total Assets	75.24%
Annual Growth Rate	-14.93%
5-Year Change	-85.57%
10-Year Change	-93.81%
Growth Volatility	32.72

Lidds AB - Net Assets Trend (2010–2024)

This chart illustrates how Lidds AB's net assets have evolved over time, based on quarterly financial data. Also explore Lidds AB assets under control for the complete picture of this company's asset base.

Annual Net Assets for Lidds AB (2010–2024)

The table below shows the annual net assets of Lidds AB from 2010 to 2024. For live valuation and market cap data, see LIDDS company net worth.

Year	Net Assets	Change
2024-12-31	Skr6.18 Million ≈ $664.96K	-55.54%
2023-12-31	Skr13.90 Million ≈ $1.50 Million	-9.45%
2022-12-31	Skr15.35 Million ≈ $1.65 Million	-68.36%
2021-12-31	Skr48.51 Million ≈ $5.22 Million	+13.32%
2020-12-31	Skr42.81 Million ≈ $4.61 Million	-71.86%
2019-12-31	Skr152.13 Million ≈ $16.37 Million	-4.03%
2018-12-31	Skr158.52 Million ≈ $17.06 Million	+24.57%
2017-12-31	Skr127.25 Million ≈ $13.69 Million	+13.09%
2016-12-31	Skr112.52 Million ≈ $12.11 Million	+12.78%
2015-12-31	Skr99.77 Million ≈ $10.74 Million	+3.53%
2014-12-31	Skr96.37 Million ≈ $10.37 Million	+28.14%
2013-12-31	Skr75.21 Million ≈ $8.09 Million	+9.57%
2012-12-31	Skr68.64 Million ≈ $7.39 Million	-5.13%
2011-12-31	Skr72.35 Million ≈ $7.79 Million	+21.66%
2010-12-31	Skr59.47 Million ≈ $6.40 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Lidds AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 280769800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	Skr7.23 Million	117.06%
Other Components	Skr3.63 Million	58.73%
Total Equity	Skr6.18 Million	100.00%

Lidds AB Competitors by Market Cap

The table below lists competitors of Lidds AB ranked by their market capitalization.

Company	Market Cap
finnCap Group PLC LSE:CAV	$361.51K
Wildpack Beverage Inc V:CANS	$362.36K
Israel Opportunity - Energy Resources LP TA:ISOP-L	$362.49K
Metgasco Ltd AU:MEL	$363.97K
Bolt Projects Holdings, Inc. NASDAQ:BSLK	$360.21K
Hardide PLC LSE:HDD	$359.60K
OVATION SCIENCE I F:0VH	$359.26K
Reco International Group Inc V:RGI	$359.06K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Lidds AB's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 13,899,000 to 6,179,000, a change of -7,720,000 (-55.5%).
Net loss of 5,938,000 reduced equity.
Other factors decreased equity by 1,782,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Skr-5.94 Million	-96.1%
Other Changes	Skr-1.78 Million	-28.84%
Total Change	Skr-	-55.54%

Book Value vs Market Value Analysis

This analysis compares Lidds AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.54x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has increased from 0.00x to 0.54x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-12-31	Skr5.41	Skr0.02	x
2011-12-31	Skr7.23	Skr0.02	x
2012-12-31	Skr6.86	Skr0.02	x
2013-12-31	Skr7.16	Skr0.02	x
2014-12-31	Skr6.78	Skr0.02	x
2015-12-31	Skr6.68	Skr0.02	x
2016-12-31	Skr5.92	Skr0.02	x
2017-12-31	Skr6.02	Skr0.02	x
2018-12-31	Skr6.58	Skr0.02	x
2019-12-31	Skr5.96	Skr0.02	x
2020-12-31	Skr1.48	Skr0.02	x
2021-12-31	Skr1.41	Skr0.02	x
2022-12-31	Skr0.45	Skr0.02	x
2023-12-31	Skr0.22	Skr0.02	x
2024-12-31	Skr0.05	Skr0.02	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Lidds AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -96.10%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -18556.25%
• Asset Turnover: 0.00x
• Equity Multiplier: 1.32x
Recent ROE (-96.10%) is below the historical average (-56.05%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	-3.15%	0.00%	0.00x	1.02x	Skr-7.82 Million
2011	-4.81%	0.00%	0.00x	1.02x	Skr-10.72 Million
2012	-5.41%	-28822.11%	0.00x	1.05x	Skr-10.58 Million
2013	-5.17%	-50869.62%	0.00x	1.02x	Skr-11.41 Million
2014	-7.33%	0.00%	0.00x	1.02x	Skr-16.70 Million
2015	-7.83%	0.00%	0.00x	1.03x	Skr-17.79 Million
2016	-5.90%	0.00%	0.00x	1.08x	Skr-17.89 Million
2017	-5.24%	-648.44%	0.01x	1.03x	Skr-19.39 Million
2018	-2.36%	-48.33%	0.05x	1.03x	Skr-19.60 Million
2019	-15.67%	0.00%	0.00x	1.04x	Skr-39.05 Million
2020	-75.53%	-9372.17%	0.01x	1.27x	Skr-36.61 Million
2021	-76.83%	-1048.68%	0.06x	1.15x	Skr-42.12 Million
2022	-240.15%	-1952.33%	0.07x	1.69x	Skr-38.39 Million
2023	-289.27%	0.00%	-0.01x	1.27x	Skr-41.60 Million
2024	-96.10%	-18556.25%	0.00x	1.32x	Skr-6.56 Million

Industry Comparison

This section compares Lidds AB's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $165,054,194
Average return on equity (ROE) among peers: -81.86%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Lidds AB (LIDDS)	Skr1.49 Million	-3.15%	0.33x	$361.27K
2cureX AB (2CUREX)	$74.34 Million	-25.47%	0.06x	$4.90 Million
Ascelia Pharma AB (publ) (ACE)	$74.33 Million	-147.03%	0.17x	$40.96 Million
AcouSort AB (ACOU)	$15.58 Million	-57.51%	0.12x	$8.97 Million
Active Biotech AB (ACTI)	$188.64 Million	-118.73%	1.64x	$17.19 Million
Alzinova AB (ALZ)	$20.63 Million	-16.51%	0.08x	$4.97 Million
AlzeCure Pharma (ALZCUR)	$182.01 Million	-28.02%	0.03x	$18.18 Million
Annexin Pharmaceuticals AB (ANNX)	$18.81 Million	-234.16%	0.42x	$11.24 Million
Alligator Bioscience AB (ATORX)	$68.52 Million	-112.06%	0.43x	$14.33 Million
BioInvent International AB (BINV)	$219.00 Million	-63.86%	0.22x	$155.44 Million
BioArctic AB (publ) (BIOA-B)	$788.68 Million	-15.19%	0.14x	$2.59 Billion

About Lidds AB

ST:LIDDS Sweden Biotechnology

Market Cap

$361.27K

Skr3.36 Million SEK

Market Cap Rank

#30651 Global

#727 in Sweden

Share Price

Skr0.02

Change (1 day)

+0.00%

52-Week Range

Skr0.01 - Skr0.10

All Time High

Skr19.64